Torbay Pharmacy Manufacturing Unit appoints md

Dr Nick Frampton to run the unit

The UK’s South Devon Healthcare NHS Foundation Trust has appointed Dr Nick Frampton as managing director of the Torbay Pharmacy Manufacturing Unit (PMU), which produces licensed pharmaceuticals, pharmaceutical specials and medical devices.

Frampton joins the firm from Advanced Medical Solutions Group, where he was vice president of sales and marketing and contributed to a period of double-digit growth. He has formerly held quality, technical and commercial roles at West Pharmaceutical Services, Ernest Jackson and Banner Pharmacaps.

You may also like

Finance

NorthEdge invests in sterile injectable CMO to accelerate international growth

Private equity firm NorthEdge has invested in sterile injectable contract manufacturer and licence holder, Torbay Pharmaceuticals (Torbay), to support its next phase of international growth
Finance

Johnson & Johnson to acquire heart failure specialist, V-Wave, for up to $1.1bn

The strategic acquisition will boost J&J's offering in the heart disease category
Research & Development

Merck acquires $700m clinical-stage bispecific antibody from Curon Biopharmaceutical

The CD3xCD19-targeting T-cell engager is currently being evaluated in Phase I/Ib/II clinical trials for a range of B-cell malignancies
Manufacturing

Adare Pharma awarded $3m by the Shapiro Administration to support Pennsylvania HQ move

The funding is part of a $16.8m initiative by Adare to expand its US footprint, while also moving into a prominent life sciences hub
Finance

iotaSciences secures equity round to advance cell biology handling solutions

The solutions can be used in R&D workflows associated with cell and gene therapy
Finance

AbbVie completes acquisition of Cerevel Therapeutics

AbbVie now owns Cerevel's clinical-stage therapeutic pipeline for the treatment of Parkinson's, schizophrenia and MDD
Finance

Oxford Nanopore bags £50m investment to boost its nanopore DNA/RNA sequencing technology

The portable sequencing machines can give researchers and biopharmaceutical manufacturers rapid insights into sample epigenetics
Subscribe now